M31.5 ICD-10-CM Code: Giant cell arteritis with polymyalgia rheumatica
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the musculoskeletal system and connective tissue (M00-M99) / Systemic connective tissue disorders (M30-M36)
M31.5
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceGiant cell arteritis with polymyalgia rheumatica
A condition where large arteries become inflamed (giant cell arteritis) and is accompanied by muscle pain and stiffness, particularly in the shoulders and hips (polymyalgia rheumatica).

Buddy Insight
Giant cell arteritis with polymyalgia rheumatica represents a combination of large vessel vasculitis with associated muscle pain and stiffness, typically affecting patients over 50 years.
CMS-HCC V28
MappedHCC 94
RAF 0.268
CMS-HCC V24
MappedHCC 40
RAF 0.421
ACA/HHS
MappedHCC 57
Varies by metal level
ESRD/PACE
MappedHCC 40
RAF 0.058
RXHCC
MappedHCC 84
RAF 0.113
Code Book Path
Inclusion Terms
OfficialICD-10-CM does not list inclusion terms for M31.5 in this effective period.
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for M31.5 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for M31.5 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for M31.5 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for M31.5 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for M31.5 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for M31.5 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is M31.5 an HCC code?
Yes. M31.5 (Giant cell arteritis with polymyalgia rheumatica) maps to Systemic Lupus Erythematosus and Other Specified Systemic Connective Tissue Disorders under the CMS-HCC V28 risk adjustment model (and Rheumatoid Arthritis and Inflammatory Connective Tissue Disease under V24), with a community non-dual aged RAF of 0.268. It is billable for payment year 2026.
Coder answer: M31.5 is billable and maps to V28 HCC 94, Systemic Lupus Erythematosus and Other Specified Systemic Connective Tissue Disorders. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- M31.5
- Description
- Giant cell arteritis with polymyalgia rheumatica
- HCC (V28)
- HCC 94 — Systemic Lupus Erythematosus and Other Specified Systemic Connective Tissue Disorders
- RAF
- 0.268
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
Work M31.5 in the Code Book — tabular path, V28 RAF, and MEAT checklist →
MEAT Criteria for M31.5
For M31.5 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed M31.5 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
M31.5 is the ICD-10-CM diagnosis code for giant cell arteritis with polymyalgia rheumatica. A condition where large arteries become inflamed (giant cell arteritis) and is accompanied by muscle pain and stiffness, particularly in the shoulders and hips (polymyalgia rheumatica). M31.5 sits in the ICD-10-CM chapter for diseases of the musculoskeletal system and connective tissue (m00-m99), within the section covering systemic connective tissue disorders (m30-m36).
Under the CMS-HCC V28 risk adjustment model, M31.5 maps to Systemic Lupus Erythematosus and Other Specified Systemic Connective Tissue Disorders (HCC 94) with a community, non-dual, aged base RAF weight of 0.268. Under the older CMS-HCC V24 model, M31.5 maps to Rheumatoid Arthritis and Inflammatory Connective Tissue Disease (HCC 40) with a community, non-dual, aged base RAF weight of 0.421. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Code both the giant cell arteritis and polymyalgia rheumatica components. Because M31.5 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for M31.5 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Code both the giant cell arteritis and polymyalgia rheumatica components
- •Document any vision complications or temporal artery involvement
Clinical Significance
Giant cell arteritis with polymyalgia rheumatica represents a combination of large vessel vasculitis with associated muscle pain and stiffness, typically affecting patients over 50 years. This condition carries risk of blindness and requires immediate high-dose corticosteroid treatment.
Documentation Requirements
- ✓Patient age typically over 50 years
- ✓Clinical evidence of giant cell arteritis (temporal artery involvement)
- ✓Concurrent polymyalgia rheumatica symptoms
- ✓Elevated inflammatory markers (ESR, CRP)
- ✓Temporal artery biopsy if performed
- ✓Assessment of visual symptoms
- ✓Response to corticosteroid therapy
- ✓Monitoring for steroid-related complications
Commonly Confused Codes
- •M31.6: Other giant cell arteritis (without polymyalgia rheumatica)
- •M35.3: Polymyalgia rheumatica (without arteritis component)
- •M31.4: Aortic arch syndrome (Takayasu arteritis)
- •G44.001: Cluster headache syndrome, unspecified (headache only)
- •H34.10: Central retinal artery occlusion, unspecified eye (visual complications only)

